What we could do now: molecular pathology of gynaecological cancer

C S Herrington

    Research output: Contribution to journalReview articlepeer-review

    6 Citations (Scopus)


    Gynaecological tumours exemplify many of the molecular paradigms of carcinogenesis. The clinical value of many of the molecular abnormalities present is now being tested and it is likely that the identification of at least some of these will become routine in the near future. This may help to refine diagnosis and guide treatment-for example, therapeutic vaccination for human papillomavirus related disease.

    Original languageEnglish
    Pages (from-to)222-224
    Number of pages3
    JournalMolecular Pathology
    Issue number4
    Publication statusPublished - Aug 2001

    Cite this